BioPharma Credit to invest $325mn in Collegium Pharmaceuticals
LONDON, UK: BioPharma Credit (LSE: BPCR) t, through its fully owned subsidiary, together with BioPharma Credit Investments V (Master) LP, has provided Collegium Pharmaceutical Inc. (Nasdaq: COLL) a commitment to enter into a new $650 million senior secured term loan…